Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 28 (1) , 53-61
- https://doi.org/10.1016/0165-5728(90)90040-t
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Characterization of opiate binding sites on membranes of rat lymphocytesJournal of Neuroimmunology, 1989
- Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies.Journal of Clinical Investigation, 1989
- Regulation of human natural cytotoxicity by enkephalins and selective opiate agonistsBrain, Behavior, and Immunity, 1988
- Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonistsJournal of Medicinal Chemistry, 1988
- Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropinLife Sciences, 1988
- Production of Neuroendocrine Peptide Hormones by the Immune SystemPublished by S. Karger AG ,1988
- Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages.Journal of Clinical Investigation, 1986
- Immunoreactive beta-endorphin in a subpopulation of mouse spleen macrophages.Journal of Clinical Investigation, 1984
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981